ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY

We present an ongoing open label phase 1 investigator-sponsored trial (NCT02893137) testing safety/efficacy of a novel therapeutic concept for recurrent glioblastoma (GBM). The intervention combines best choice chemotherapy with tumor treating fields (TTFields) and personalized targeted skull remode...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Korshoej, Anders Rosendal, Hansen, Frederik Lundgaard, Slavka, Lukacova, Cortnum, Søren Ole Stigaard, Lassen-Ramshad, Yasmin, Guldberg, Trine Lignell, Rahbek, Christian, Mikic, Nikola, Thielscher, Axel, Sørensen, Jens Christian Hedemann, von Oettingen, Gorm Burckhardt
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692142/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.045
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados